These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3014531)

  • 1. Mutations of the ras gene product p21 that abolish guanine nucleotide binding.
    Clanton DJ; Hattori S; Shih TY
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5076-80. PubMed ID: 3014531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural significance of the GTP-binding domain of ras p21 studied by site-directed mutagenesis.
    Clanton DJ; Lu YY; Blair DG; Shih TY
    Mol Cell Biol; 1987 Sep; 7(9):3092-7. PubMed ID: 3118192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and biological properties of the human N-ras p21 protein.
    Trahey M; Milley RJ; Cole GE; Innis M; Paterson H; Marshall CJ; Hall A; McCormick F
    Mol Cell Biol; 1987 Jan; 7(1):541-4. PubMed ID: 3550423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ras gene family.
    Lowy DR; Willumsen BM
    Cancer Surv; 1986; 5(2):275-89. PubMed ID: 3096566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and function of p21 ras proteins.
    Shih TY; Hattori S; Clanton DJ; Ulsh LS; Chen ZQ; Lautenberger JA; Papas TS
    Gene Amplif Anal; 1986; 4():53-72. PubMed ID: 3333361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation.
    Pai EF; Kabsch W; Krengel U; Holmes KC; John J; Wittinghofer A
    Nature; 1989 Sep; 341(6239):209-14. PubMed ID: 2476675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. rasH mutants deficient in GTP binding.
    Der CJ; Pan BT; Cooper GM
    Mol Cell Biol; 1986 Sep; 6(9):3291-4. PubMed ID: 3097518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and biological activities of N-ras proteins.
    Geis AM; Nicolson M; Goldman RA
    Biochem Biophys Res Commun; 1986 Sep; 139(2):771-9. PubMed ID: 3533068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras p21 proteins with high or low GTPase activity can efficiently transform NIH/3T3 cells.
    Lacal JC; Srivastava SK; Anderson PS; Aaronson SA
    Cell; 1986 Feb; 44(4):609-17. PubMed ID: 3004741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular heterogeneity of the smg-21/Krev-1/rap1 proteins, a GTP-binding protein having the same effector domain as ras p21s, in bovine aortic smooth muscle membranes.
    Kawata M; Kawahara Y; Sunako M; Araki S; Koide M; Tsuda T; Fukuzaki H; Takai Y
    Oncogene; 1991 May; 6(5):841-8. PubMed ID: 1646988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of phospholipids and ADP-ribosylation on GTP hydrolysis by Escherichia coli-synthesized Ha-ras-encoded p21.
    Tsai SC; Adamik R; Moss J; Vaughan M; Manne V; Kung HF
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8310-4. PubMed ID: 3001695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asparagine 26, glutamic acid 31, valine 45, and tyrosine 64 of Ras proteins are required for their oncogenicity.
    Nur-E-Kamal MS; Sizeland A; D'Abaco G; Maruta H
    J Biol Chem; 1992 Jan; 267(3):1415-8. PubMed ID: 1730690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain.
    Adari H; Lowy DR; Willumsen BM; Der CJ; McCormick F
    Science; 1988 Apr; 240(4851):518-21. PubMed ID: 2833817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytoplasmic protein GAP is implicated as the target for regulation by the ras gene product.
    Calés C; Hancock JF; Marshall CJ; Hall A
    Nature; 1988 Apr; 332(6164):548-51. PubMed ID: 2833702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Possible mechanisms of disorders of GTPase activity with substitutions at the 12th and 61st codons of the p21 H-ras protein].
    Lalaiants IE
    Vopr Onkol; 1987; 33(7):9-15. PubMed ID: 3039739
    [No Abstract]   [Full Text] [Related]  

  • 16. trans-Dominant suppressor mutations of the H-ras oncogene.
    Ogiso Y; Gutierrez L; Wrathall LS; Lu YY; Blair DG; Clanton DJ; Hwang YW; Shih TY
    Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of ras GTP-binding mutants using an in situ colony-binding assay.
    Feig LA; Pan BT; Roberts TM; Cooper GM
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4607-11. PubMed ID: 3088563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternate mechanisms of ras activation are complementary and favor and formation of ras-GTP.
    Patel G; MacDonald MJ; Khosravi-Far R; Hisaka MM; Der CJ
    Oncogene; 1992 Feb; 7(2):283-8. PubMed ID: 1549350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of Era, an essential GTP-binding protein of Escherichia coli.
    Shimamoto T; Inouye M
    FEMS Microbiol Lett; 1996 Feb; 136(1):57-62. PubMed ID: 8919456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion mutants of Harvey ras p21 protein reveal the absolute requirement of at least two distant regions for GTP-binding and transforming activities.
    Lacal JC; Anderson PS; Aaronson SA
    EMBO J; 1986 Apr; 5(4):679-87. PubMed ID: 3011420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.